Market Tracker

05/22 3:28pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.90
BATS BZX Real-Time Price
As of 3:26pm ET
 -0.09 / -1.29%
Today’s Change
4.00
Today|||52-Week Range
11.72
-20.14%
Year-to-Date
PetMed (PETS) Beats Earnings, Revenue Estimates in Q4
May 09 / Zacks.com - Paid Partner Content
Align Technology Invisalign Sales Strong, Currency Woes Stay
May 08 / Zacks.com - Paid Partner Content
Henry Schein (HSIC) Tops Q1 Earnings, Reaffirms '17 View
May 09 / Zacks.com - Paid Partner Content
Qiagen Banks on Molecular Diagnostic amid Currency Woes
May 08 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Tops Q4 Earnings, Sales, Issues 2018 View
May 09 / Zacks.com - Paid Partner Content
CVS Down on Weak Earnings, Pharmacy Services Remains Strong
May 08 / Zacks.com - Paid Partner Content
Phibro (PAHC) Posts In Line Earnings in Q3, Revises View
May 09 / Zacks.com - Paid Partner Content
VWR Corp (VWR) Beats on Q1 Earnings, Awaits Merger Closure
May 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close6.99
Today’s open6.98
Day’s range6.83 - 7.08
Volume35,852
Average volume (3 months)1,314,820
Market cap$490.9M
Dividend yield--
Data as of 3:26pm ET, 05/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-564.00%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+700.24%
P/E ratio69.1
Price/Sales8.73
Price/Book4.68

Competitors

 Today’s
change
Today’s
% change
ACIUAC Immune Ltd+0.08+0.96%
RETAReata Pharmaceutical...+0.17+0.69%
SCLNSciClone Pharmaceuti...-0.02-0.26%
SCMPSucampo Pharmaceutic...+0.02+0.24%
Data as of 3:27pm ET, 05/22/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$69.4M
Annual profit (last year)$10.8M
Net profit margin15.56%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark Robert Baker
CFO, Principal Accounting Officer &
Senior VP
Patrick Fabbio
Corporate headquarters
Tarrytown, New York

Forecasts